Press releases
- Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002
- Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders
- Gabather reports initial positive results from the EEG/fMRI target engagement study
Key statistics
On Wednesday, Gabather AB (GABA:STO) closed at 1.63, 105.81% above the 52 week low of 0.792 set on Feb 29, 2024.
52-week range
Open | 1.67 |
---|---|
High | 1.67 |
Low | 1.56 |
Bid | 1.52 |
Offer | 1.63 |
Previous close | 1.63 |
Average volume | 40.39k |
---|---|
Shares outstanding | 18.89m |
Free float | 18.88m |
P/E (TTM) | -- |
Market cap | 31.54m SEK |
EPS (TTM) | -0.652 SEK |
Data delayed at least 15 minutes, as of May 22 2024 17:00 BST.
More ▼